Anticoagulant properties in vitro of heparan sulphates.

[1]  E. Johnson.  Heparan sulphates from porcine intestinal mucosa. Preparation and physicochemical properties. , 1984, Thrombosis research.

[2]  B. Mulloy,et al.  Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates. , 1983, Arzneimittel-Forschung.

[3]  D. Thomas,et al.  A low molecular weight heparin compared with unfractionated heparin. , 1982, Thrombosis research.

[4]  W. Lewis,et al.  Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans. , 1982, Thrombosis research.

[5]  P. Gaffney,et al.  A Comparison of Pentosan Polysulphate and Heparin II: Effects of Subcutaneous Injection , 1982, Thrombosis and Haemostasis.

[6]  I. Danishefsky,et al.  Preparation of highly stable antithrombin-sepharose and utilization for the fractionation of heparin. , 1982, Thrombosis research.

[7]  P. Colburn,et al.  Anti-clotting activity of endothelial cell cultures and heparan sulfate proteoglycans. , 1982, Biochemical and biophysical research communications.

[8]  H. Ijichi,et al.  Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine. , 1981, Thrombosis research.

[9]  K. Shimada,et al.  Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells. , 1981, The Journal of clinical investigation.

[10]  T. Kirkwood,et al.  Biometric principles in clotting and clot lysis assays. , 1980, Clinical and laboratory haematology.

[11]  J. Stocks,et al.  In vivo release of anti-Xa clotting activity by a heparin analogue. , 1980, Thrombosis research.

[12]  W. Long,et al.  Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas. , 1980, Thrombosis research.

[13]  V. Kakkar,et al.  Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III. , 1979, Biochimica et biophysica acta.

[14]  T. Barrowcliffe,et al.  Anticoagulant Activities of High and Low Molecular Weight Heparin Fractions , 1979, British journal of haematology.

[15]  B. Mulloy,et al.  Anti-factor Xa activity of heparan sulphate. , 1979, Thrombosis research.

[16]  W. Salsgiver,et al.  Normal human plasma contains a naturally occurring antagonist of activated factor X inhibitor (antithrombin III) activity. , 1979, Thrombosis research.

[17]  L. Berry,et al.  Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta. , 1978, Thrombosis research.

[18]  V. Kakkar,et al.  Neutralization of Heparin in Plasma by Platelet Factor 4 and Protamine Sulphate , 1978, British journal of haematology.

[19]  M. Höök,et al.  Glycosaminoglycans and their binding to biological macromolecules. , 1978, Annual review of biochemistry.

[20]  T. Barrowcliffe,et al.  Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration. , 1976, Thrombosis research.

[21]  C. Dietrich,et al.  Characteristic distribution of sulfated mucopolysaccharides in different tissues and in their respective mitochondria. , 1976, Biochemical and biophysical research communications.

[22]  U. Abildgaard,et al.  The anticoagulant effect of heparan sulfate and dermatan sulfate. , 1976, Thrombosis research.

[23]  V. Buonassisi,et al.  Enzymatic degradation of heparin-related mucopolysaccharides from the surface of endothelial cell cultures. , 1975, Biochimica et biophysica acta.

[24]  T BITTER,et al.  A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.